CINECA IRIS Institutional Research Information System

GIORDANO, Roberta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.716
EU - Europa 4.444
AS - Asia 2.961
SA - Sud America 112
AF - Africa 41
OC - Oceania 37
Continente sconosciuto - Info sul continente non disponibili 3
Totale 15.314
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.588
CN - Cina 1.367
IT - Italia 858
IE - Irlanda 595
SG - Singapore 569
SE - Svezia 486
UA - Ucraina 439
KR - Corea 434
DE - Germania 421
FR - Francia 390
FI - Finlandia 355
GB - Regno Unito 215
PL - Polonia 190
VN - Vietnam 135
JP - Giappone 117
CA - Canada 101
NL - Olanda 79
AT - Austria 67
TR - Turchia 62
ES - Italia 58
RU - Federazione Russa 56
BE - Belgio 54
IN - India 51
BR - Brasile 47
PH - Filippine 45
ID - Indonesia 39
DK - Danimarca 35
AU - Australia 34
GR - Grecia 32
AR - Argentina 31
UZ - Uzbekistan 29
HK - Hong Kong 21
PT - Portogallo 18
TW - Taiwan 17
MX - Messico 16
CH - Svizzera 14
NO - Norvegia 14
RO - Romania 14
CO - Colombia 13
IR - Iran 12
SA - Arabia Saudita 12
TH - Thailandia 11
HR - Croazia 10
RS - Serbia 9
SN - Senegal 8
EG - Egitto 7
LB - Libano 7
CZ - Repubblica Ceca 6
DZ - Algeria 6
PE - Perù 6
AE - Emirati Arabi Uniti 5
MY - Malesia 5
TN - Tunisia 5
ZA - Sudafrica 5
EC - Ecuador 4
HU - Ungheria 4
IL - Israele 4
SK - Slovacchia (Repubblica Slovacca) 4
BN - Brunei Darussalam 3
CL - Cile 3
CR - Costa Rica 3
CU - Cuba 3
CY - Cipro 3
LT - Lituania 3
LV - Lettonia 3
MU - Mauritius 3
NZ - Nuova Zelanda 3
VE - Venezuela 3
BD - Bangladesh 2
BG - Bulgaria 2
EU - Europa 2
GY - Guiana 2
KE - Kenya 2
ME - Montenegro 2
MK - Macedonia 2
PA - Panama 2
PK - Pakistan 2
PR - Porto Rico 2
PS - Palestinian Territory 2
SI - Slovenia 2
SM - San Marino 2
UG - Uganda 2
UY - Uruguay 2
BO - Bolivia 1
BY - Bielorussia 1
EE - Estonia 1
GE - Georgia 1
IM - Isola di Man 1
IQ - Iraq 1
JM - Giamaica 1
JO - Giordania 1
KG - Kirghizistan 1
KH - Cambogia 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MA - Marocco 1
MT - Malta 1
NG - Nigeria 1
OM - Oman 1
SD - Sudan 1
Totale 15.313
Salva come PNG Salva come JPEG
Città #
Chandler 1.067
Beijing 1.011
Dublin 585
Santa Clara 560
Singapore 466
Houston 431
Ashburn 288
Fairfield 272
Dearborn 261
Ann Arbor 260
Jacksonville 256
Villeurbanne 233
Wilmington 218
Princeton 208
Medford 201
Nyköping 184
Torino 170
Columbus 154
Woodbridge 150
Warsaw 143
Redwood City 131
Seattle 107
Cambridge 100
Pisa 89
Milan 82
Boston 75
Dong Ket 74
Fremont 68
Vienna 63
New York 52
San Mateo 51
Munich 48
Boardman 45
Rome 45
Toronto 45
Turin 45
Guangzhou 34
Tokyo 34
Norwalk 33
Brussels 32
Jakarta 32
Istanbul 29
Nanjing 29
Shanghai 29
Washington 27
Chicago 26
Hefei 26
Verona 26
Los Angeles 25
Rochester 24
London 23
Falls Church 22
Helsinki 22
Kunming 20
San Diego 18
Paris 17
Jinan 16
Lachine 16
Buenos Aires 15
Phoenix 15
Pune 15
Silver Spring 15
Chengdu 14
Ottawa 13
Taipei 13
Ankara 12
Halle 12
Hong Kong 12
Mountain View 12
Perugia 11
Fuzhou 10
Gainesville 10
Osaka 10
Portland 10
Shenyang 10
São Paulo 10
Zhengzhou 10
Belgrade 9
Buffalo 9
Hangzhou 9
Madrid 9
Moscow 9
Nanchang 9
Polska 9
Amsterdam 8
Brisbane 8
Edinburgh 8
Genova 8
Las Vegas 8
Leiden 8
San Francisco 8
Vancouver 8
Wuhan 8
Berlin 7
Copenhagen 7
Padova 7
Philadelphia 7
Weymouth 7
Alessandria 6
Bogotá 6
Totale 9.209
Salva come PNG Salva come JPEG
Nome #
Long-term follow-up in adrenal incidentalomas: an Italian Multicenter Study. 484
QUALITY-OF-LIFE IN EUROPEAN PATIENTS WITH ADDISON'S DISEASE; VALIDITY OF THE DISEASE-SPECIFIC QUESTIONNAIRE 454
Glucose metabolism in patients with subclinical Cushing's syndrome. 377
Management of adrenocortical carcinoma: a consensus statement of the Italian Society of Endocrinology (SIE) 362
CUSHING'S SYNDROME IS ASSOCIATED WITH SLEEP ALTERATIONS DETECTED BY WRIST ACTIGRAPHY 351
Screening of Cushing's Syndrome in Outpatients with Type 2 Diabetes: Results of a Prospective Multicentric Study in Italy. 300
BCLI POLYMORPHISM OF THE GLUCOCORTICOID RECEPTOR GENE IS ASSOCIATED WITH INCREASED OBESITY, IMPAIRED GLUCOSE TOLERANCE AND DYSLIPIDEMIA IN PATIENTS WITH ADDISON’S DISEASE 298
AUTOANTIBODY RESPONSE AGAINST NALP5/MATER IN PRIMARY OVARIAN INSUFFICIENCY AND IN AUTOIMMUNE ADDISON’S DISEASE 270
Do glucocorticoids induce addiction in humans? 266
ACUTE ADMINISTRATION OF ALPRAZOLAM, A BENZODIAZEPINE ACTIVATING GABA RECEPTORS, INHIBITS CORTISOL SECRETION IN PATIENTS WITH SUBCLINICAL BUT NOT OVERT CUSHING'S SYNDROME 256
Enhanced oxidative stress and platelet activation in patients with Cushing's syndrome. 244
AUTOIMMUNE POLYENDOCRINOPATHY-CANDIDIASIS-ECTODERMAL-DYSTROPHY (APECED) IN SICILY: CONFIRMATION THAT R203X IS THE PECULIAR AIRE GENE MUTATION 234
Involvement of hypothalamus autoimmunity in patients with autoimmune hypopituitarism: role of antibodies to hypothalamic cells. 211
Tryptophan hydroxylase autoantibodies as markers of a distinct autoimmune gastrointestinal component of autoimmune polyendocrine syndrome type 1. 208
USEFULNESS OF AN AD HOC QUESTIONNAIRE (ACRO-CQ) FOR THE SYSTEMATIC ASSESSMENT OF ACROMEGALY COMORBIDITIES AT DIAGNOSIS AND THEIR MANAGEMENT AT FOLLOW-UP 196
MOLECULAR BACKGROUND AND GENOTYPE-PHENOTYPE CORRELATION IN APECED PATIENTS FROM CAMPANIA AND IN THEIR RELATIVES 187
IDENTIFICATION OF RISK CONDITIONS FOR THE DEVELOPMENT OF ADRENAL DISORDERS: HOW OPTIMIZED PUBMED SEARCH STRATEGIES MAKES THE DIFFERENCE 187
IMPROVEMENT OF ANTHROPOMETRIC AND METABOLIC PARAMETERS, AND QUALITY OF LIFE FOLLOWING TREATMENT WITH DUAL-RELEASE HYDROCORTISONE IN PATIENTS WITH ADDISON'S DISEASE 184
Endocrine Autoimmunity in Down's Syndrome 164
Neuroendocrine effects of citalopram, a selective serotonine re-uptake inhibitor, during life span in humans 150
Alprazolam, a benzodiazepine, does not modify the ACTH and cortisol response to hCRH and AVP, but blunts the cortisol response to ACTH in humans. 148
ROLE OF MINERALOCORTICOID RECEPTORS ON HPA AXIS IN HUMANS 125
Secondary adrenal insufficiency: Where is it hidden and what does it look like? 120
THE ACUTE EFFECT OF FLUDROCORTISONE ON BASAL AND HCRH-STIMULATED HYPOTHALAMIC-PITUITARY-ADRENAL (HPA) AXIS IN HUMANS 118
Benzodiazepines and anterior pituitary function. 113
EVALUATION OF BASAL AND STIMULATED ACTIVITY OF THE HYPOTHALAMO-PITUITARY-ADRENAL (HPA) AXIS IN PATIENTS WITH PRIMARY HYPERALDOSTERONISM 113
DUAL-RELEASE HYDROCORTISONE IN ADDISON’S DISEASE-A REVIEW OF THE LITERATURE 110
Effect of acute and prolonged mineralocorticoid receptor blockade on spontaneous and stimulated hypothalamus-pituitary-adrenal (HPA) axis in humans 107
GLUCOCORTICOID RECEPTOR POLYMORPHISMS AND METABOLIC-CARDIOVASCULAR PROFILE IN PATIENTS WITH ADDISON’S DISEASE UNDER REPLACEMENT THERAPY 105
EFFECTS OF CETRORELIX, A GnRH-RECEPTOR ANTAGONIST, ON GONADAL AXIS IN WOMEN WITH FUNCTIONAL HYPOTHALAMIC AMENORRHEA 105
EFFECTS OF GNRH-RECEPTOR BLOCKADE ON GONADAL AXIS IN WOMEN WITH FUNCTIONAL HYPOTHALAMIC AMENORRHEA 103
Do muscle fiber conduction slowing and decreased levels of circulating muscle proteins represent sensitive markers of steroid myopathy? A pilot study in Cushing’s disease 103
Testing pituitary function in aging individuals 103
HYPERCORTISOLISM DUE TO CUSHING’S DISEASE IS ASSOCIATED TO DERANGED GHRELIN SECRETION AND ACTION 101
Effects of alprazolam, a benzodiazepine, on the ACTH-, GH- and PRL-releasing activity of hexarelin, a synthetic peptidyl GH secretagogue (GHS), in patients with simple obesity and in patients with Cushing's disease. 98
Alprazolam (a benzodiazepine activating GABA receptor) reduces the neuroendocrine responses to insulin-induced hypoglycaemia in humans. 97
Ageing, growth hormone and physical performance. 96
EFFECT OF PROLONGED TREATMENT WITH POTASSIUM CANRENOATE, A MR ANTAGONIST, ON BASAL AND STIMULATED HYPOTHALAMUS-PITUITARY-ADRENAL (HPA) AXIS IN HUMANS 92
Adrenal sensitivity to adrenocorticotropin 1-24 is reduced in patients with autoimmune polyglandular syndrome 91
SENSITIVITY AND SPECIFICITY OF DIFFERENT PROVOCATIVE TESTS ASSESSING THE FUNCTION OF HYPOTHALAMO-PITUITARY-ADRENAL (HPA) AXIS IN PATIENTS SUSPECTED FOR SECONDARY HYPOADRENALISM 91
ADRENAL SENSITIVITY TO ACTH1-24 AS FUNCTION OF AGE, BODY WEIGHT AND PITUITARY FUNCTION 91
Biologic activities of growth hormone secretagogues in humans. 90
GHRH and GH secretagogues: clinical perspectives and safety 88
Alprazolam, a benzodiazepine, blunts but does not abolish the ACTH and cortisol response to hexarelin, a GHRP, in obese patients. 88
DIFFERENT ENDOCRINE-METABOLIC ABNORMALITIES BETWEEN “PURE” 45,XO TURNER’S SYNDROME AND MOSAICS 88
THE ACUTE EFFECT OF A MINERALOCORTICOID RECEPTOR AGONIST ON CORTICOTROPE SECRETION IN ADDISON'S DISEASE 88
ADRENAL SENSITIVITY TO ACTH1-24 AS FUNCTION OF AGE, BODY WEIGHT AND PITUITARY FUNCTION 88
METABOLIC AND CARDIOVASCULAR RISK FACTORS IN PATIENTS WITH CUSHING’S SYNDROME OF DIFFERENT ETIOLOGY BEFORE AND 1 YEAR AFTER DISEASE REMISSION 88
METABOLIC AND CARDIOVASCULAR PROFILE IN PATIENTS WITH ADDISON’S DISEASE UNDER CONVENTIONAL GLUCOCORTICOID REPLACEMENT 87
Hypopituitaric patients with corticotropin insufficiency show marked impairment of the cortisol response to ACTH (1-24) independently of the duration of the disease. 86
GHRELIN SECRETION IS INHIBITED BY GLUCOSE LOAD AND INSULIN-INDUCED HYPOGLYCEMIA BUT UNAFFECTED BY GLUCAGON AND ARGININE IN HUMANS 85
CORTICOTROPH AND ADRENAL RESPONSIVENESS TO hCRH, HEXARELIN AND ACTH IN YOUNG AND ELDERLY SUBJECTS 84
Metabolic and cardiovascular profile in patients with Addison's disease under conventional glucocorticoid replacement 83
CONVENTIONAL GLUCOCORTICOID REPLACEMENT THERAPY IN PATIENTS WITH ADDISON’S DISEASE: EFFECT ON METABOLIC AND BONE PARAMETERS 83
Effects of free fatty acids on ACTH and cortisol secretion in anorexia nervosa 81
HYPOTHALAMO-PITUITARY-ADRENAL (HPA) AXIS SENSITIVITY TO THE NEGATIVE FEED-BACK ACTION OF CORTISOL IN HUMANS 81
ADULT PATIENTS WITH DOWN’S SYNDROME SHOW ENHANCED BASAL TSH LEVELS BUT NORMAL TSH RESPONSE TO TRH 81
Ghrelin, hypothalamus-pituitary-adrenal (HPA) axis and Cushing's syndrome 80
HORMONAL, METABOLIC AND BONE EVALUATION IN A SERIES OF ADRENAL INCIDENTALOMAS 80
FEMALE PATIENTS WITH DOWN SYNDROME (DS) SHOW A GREATER INSULIN RESISTANCE IN COMPARISON WITH NORMAL FEMALES (NF) 80
BASAL AND STIMULATED GH SECRETION IN CUSHING’S SYNDROME: EFFECTS OF GHRELIN AND GHRH+ARGININE 79
A Study of the serotoninergic tone in Healthy subjects and diabetic patients treated by a clinical-paedagogic approach (Group Care) or traditional care. 79
PATIENTS WITH AUTOIMMUNE DISEASES SHOWED ENHANCED BASAL AND STIMULATED CORTICOTROPH SECRETION 78
EFFECT OF SHORT TERM ADMINISTRATION OF LOW RHGH DOSE ON IGF-I LEVELS AS FUNCTION OF SEX, AGE AND PATHOPHYSIOLOGICAL CONDITIONS 78
EVALUATION OF BASAL AND STIMULATED HYPOTHALAMUS-PITUITARY-ADRENAL (HPA) ACTIVITY IN PRIMARY HYPERALDOSTERONISM 78
Tyr-Ala-Hexarelin, a synthetic octapeptide, possesses the same endocrine activities of Hexarelin and GHRP-2 in humans. 77
TYR-ALA-HEXARELIN, A SYNTHETIC OCTAPEPTIDE, HAS THE SAME ENDOCRINE ACTIVITIES OF HEXARELIN AND GHRP-2 IN HUMANS 77
NEUROENDOCRINE EFFECTS OF CITALOPRAM, A SELECTIVE SEROTONIN RE-UPTAKE INHIBITOR (SSRI), DURING LIFESPAN IN HUMANS 76
METABOLIC AND CARDIOVASCULAR OUTCOMES IN PATIENTS WITH CUSHING’S SYNDROME OF DIFFERENT AETIOLOGY DURING ACTIVE DISEASE AND 1 YEAR AFTER REMISSION 76
COMPARISON BETWEEN ITT, METYRAPONE AND ACTH STIMULATION WITH HIGH, LOW AND VERY LOW DOSES FOR DIAGNOSIS OF SECONDARY HYPOADRENALISM 76
NEUROENDOCRINE EFFECT OF CITALOPRAM, A SELECTIVE SEROTONIN RE-UPTAKE INHIBITOR (SSRI), IN ANOREXIA NERVOSA 76
WRIST ACTIGRAPHY DOES NOT REVEAL SLEEP DISTURBANCES IN PATIENTS WITH ADDISON’S DISEASE UNDER CONVENTIONAL GLUCOCORTICOID REPLACEMENT THERAPY 76
Neuroregulation of the hypothalamus-pituitary-adrenal (Hpa) axis in humans: effects of Gaba-, mineralcortoid-, and gh-secretagogue-receptor modulation 76
THE INHIBITORY EFFECT OF FLUDROCORTISONE ON HPA AXIS IS NOT ONLY EXERTED THROUGH HIPPOCAMPAL MR RECEPTORS: POSSIBLE CLINICAL IMPLICATIONS 75
Low hexarelin dose and pyridostigmine have additive effect and potentiate to the same extent the GHRH-induced GH response in man. 74
L-Arginine 74
Comparison between cortisol’s and dexamethasone’s negative feedback action in humans: evidence for preferential sensitivity to the natural glucocorticoid 74
Reference ranges of late-night salivary cortisol and cortisone measured by LC–MS/MS and accuracy for the diagnosis of Cushing’s syndrome 74
Hypothalamus-pituitary-adrenal axis evaluation in patients with hypothalamo-pituitary disorders: comparison of different provocative test 73
Long-term morphological, hormonal and clinical follow-up in a single unit on 118 patients with adrenal incidentalomas 73
Endocrine function is altered in chronic migraine patients with medication-overuse 72
Ghrelin and synthetic GH secretagogues. 72
ENDOCRINE DISORDERS 72
EFFECTS OF ALPRAZOLAM, A BENZODIAZEPINE, ON THE GH, ACTH, CORTISOL AND CATECHOLAMINE RESPONSES TO INSULIN-INDUCED HYPOGLYCEMIA IN HUMANS 72
Hypothalamus-pituitary-adrenal hyperactivity in human aging is partially refractory to stimulation by mineralocorticoid receptor blockade 71
Predictors of recurrence of pheochromocytoma and paraganglioma: a multicenter study in Piedmont, Italy 71
Free fatty acids exert an inhibitory effect on ACTH and cortisol secretion in humans 70
PATIENTS WITH DOWN’S SYNDROME (DS) ARE INSULIN RESISTANT INDEPENDENTLY OF BODY MASS INDEX (BMI) 70
PATIENTS WITH AUTOIMMUNE DISEASES SHOW IMPAIRED ADRENAL SENSITIVITY TO ACTH 1-24 BUT ENHANCED BASAL AND STIMULATED CORTICOTROPH SECRETION 70
METABOLIC MODULATION OF GHRELIN SECRETION IN HUMANS 69
PATIENTS WITH AUTOIMMUNE POLYGLANDULAR SYNDROME SHOW REDUCED ADRENAL SENSITIVITY OF CORTISOL, DHEA AND ALDOSTERONE TO THE STIMULATORY EFFECT OF ACTH 1-24 69
Growth hormone treatment in human ageing: benefits and risks 68
COMPARISON BETWEEN CORTISOL AND DEXAMETHASONE NEGATIVE FEEDBACK ACTION IN HUMANS 67
Neuroendocrine function is altered in patients with chronic migraine and medication-overuse headache 67
SHOULD ALL PATIENTS WITH ADRENAL INSUFFICIENCY OR A SUBGROUP OF PATIENTS WITH PREDIABETES BE TREATED WITH DUAL-RELEASE HYDROCORTISONE? 67
EFFECTS OF CORTISTATIN-17 AND SOMATOSTATIN-14 ON ACTH AND CORTISOL HYPERSECRETION IN PATIENTS WITH CUSHING’S DISEASE 67
A New Clinical Model to Estimate the Pre-Test Probability of Cushing's Syndrome: The Cushing Score 67
The adrenal sensitivity to ACTH stimulation is preserved in anorexia nervosa 66
Adrenocorticotropin and cortisol hyperresponsiveness to hexarelin in patients with Cushing's disease bearing a pituitary microadenoma, but not in those with macroadenoma. 66
MINERALCORTICOID RECEPTOR ANTAGONISTS AS A NEW TOOL TO INVESTIGATE THE HPA AXIS IN HUMANS 66
Totale 12.120
Salva come PNG Salva come JPEG
Categoria #
all - tutte 46.227
article - articoli 0
book - libri 0
conference - conferenze 14.663
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 60.890
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.432 0 0 0 0 0 426 274 165 187 169 143 68
2020/20211.561 188 109 93 69 196 48 136 139 140 147 107 189
2021/20221.670 35 47 54 104 83 70 160 95 72 152 341 457
2022/20232.895 320 255 92 308 246 724 207 194 292 75 121 61
2023/20241.259 160 210 76 79 77 182 50 60 30 58 91 186
2024/20251.738 46 278 88 330 818 178 0 0 0 0 0 0
Totale 15.881